Navigation Links
3SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results
Date:8/15/2011

arding: revenue guidance, business prospects of the Fund, product pricing trends, revenue contribution of new products, tendering process in government procurements, exports prospects, regulatory approval in new markets, business objectives, market size , dialysis growth, product development,  clinical trial progress, regulatory approval process, collaborations, acquisitions and licensing, impact of government policies and regulations, production capacity, capital expense, and future operations and strategies. Forward-looking statements can be identified by such terminology as "believe," "expect," "plans," "strategy," "potential", "prospects," "forecast," "estimate," "project," "anticipate," "aim," "will" or "would", "may" or "might", and words, phrases, expressions, and usages of similar meaning or substance or the negative thereof.

Forward-looking statements are based on management's current assumptions, beliefs, expectations, and projections, in light of the information currently available, and actual results could differ materially from those implied or expressed by the forward-looking statements. Among the factors that could cause 3SBio's actual results to differ from what 3SBio currently anticipates may include: government policies, actions and measures; evolving healthcare reform at the central government and the provincial government level; regulatory environment and other risks in a new market; the ability of the Fund to raise additional capital; the ability of the Fund to invest successfully, in financial and strategic terms; regulatory compliance risk; the ability of 3SBio or any source it relies on to estimate or forecast accurately; competition from other domestic and foreign pharmaceutical companies; the market growth for pharmaceutical products in China; market acceptance of 3SBio products; hospital or patient demand for our products; the completion and results of 3SBio's ongoing clinical trials; receipt and timing of regulatory approvals
'/>"/>

SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. 3SBio Inc. Schedules Unaudited Second Quarter 2011 Results
2. 3SBio Inc. Announces SFDA Approval of High-Dose EPIAO
3. 3SBio Announces Conversion of Isotechnika Debenture
4. 3SBio Inc. Schedules Third Quarter 2010 Unaudited Financial Results
5. 3SBio Announces Partial Conversion of Isotechnika Debenture
6. 3SBio Announces Investor Conference Schedule
7. 3SBio and Isotechnika Pharma Announce Strategic Partnership to Develop and Commercialize Voclosporin in China
8. 3SBio Inc. Announces Results of Annual General Meeting
9. NewCardio Announces Financial Results for Its 2011 Second Quarter
10. Dehaier Medical Announces Record Second Quarter 2011 Financial Results
11. Emdeon Announces Support for Electronic Prescribing of Controlled Substances Using the DEA-Allowed Quicker-to-Market Approach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 The clinical ... can be the difference between a product,s success or ... map and stratify KOL targets – and then to ... type of strong relationships upon which successful KOL engagement ... pharma companies have identified internal inconsistencies in their KOL ...
(Date:8/29/2014)... 2014 Pomerantz LLP has filed a class ... (NASDAQ: EDAP ) and certain of its ... Court, Southern District of New York ... a class consisting of all persons or entities who ... 30, 2014, inclusive (the "Class Period"). This class action seeks ...
(Date:8/29/2014)... PARK, Calif. , Aug. 29, 2014 ... Medical as CEO and member of the Board of ... decades of medical device development and commercialization experience, including ... field. Mr. Engelson previously served as a Partner of ... as President and CEO of two Foundry start-ups. Mr. ...
Breaking Medicine Technology:Implementing a Strategic Thought Leader Management & Engagement System 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... , LAUSANNE, Switzerland, October 15 ... low-cost, integrated molecular and,immunodiagnostics based on its proprietary micro-technology ... equity financing round. The,Company raised EUR 10 million ( ... investors. , The deal was ...
... Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the ... http://www.cordblood-america.com ) focused on bringing the life ... for families nationwide and internationally, today addressed shareholder questions ... interview of Matthew Schissler, founder and CEO, by analyst ...
Cached Medicine Technology:Biocartis Raises EUR10 Million in Series A Financing Round 2Biocartis Raises EUR10 Million in Series A Financing Round 3Cord Blood America Details Las Vegas Laboratory Progress in Analyst Interview 2Cord Blood America Details Las Vegas Laboratory Progress in Analyst Interview 3
(Date:8/30/2014)... Barcelona, Spain Saturday 30 August 2014: The ... oral anticoagulants in pulmonary embolism are published today ... at ESC Congress by Professor Stavros V. Konstantinides ... "2014 ESC Guidelines on the diagnosis and management ... in European Heart Journal (1) and on the ...
(Date:8/29/2014)... 30, 2014 Indosoft, Inc. , ... announces the release of its most advanced contact center ... of new features as well as updates to existing ... , Q-Suite functionality on the presentation side has received ... into the script builder. This WYSIWYG editor allows ...
(Date:8/29/2014)... 29, 2014 According to the latest review ... to lose weight quickly, safely and naturally. The new method ... be amazingly fast, too. , Daily Gossip writes in ... not only teach patients how to eliminate the extra pounds, ... results when it comes to body modeling. , The ...
(Date:8/29/2014)... The new review that can be read on ... system that will permanently eliminate the symptoms of this disease. ... achieve a cure in as fast as 30 to 60 ... about one week. , The Tinnitus Miracle review indicates ... mild hearing loss, pain in the ear and dizziness. Read ...
(Date:8/29/2014)... August 29, 2014 Panic attacks are ... the feeling of intense stress and fear, which appears ... the sufferer, causing insecurity and affecting relationships. , A ... there are many symptoms that patients can deal with. ... these symptoms. Overcoming panic attacks is extremely important for ...
Breaking Medicine News(10 mins):Health News:First recommendations on all new oral anticoagulants in pulmonary embolism published 2Health News:Indosoft Releases Q-Suite 5.7.7 2Health News:Flat Belly Forever Review Exposes the Way to Eliminate Body Fat Easily 2Health News:Tinnitus Miracle Review Reveals How to Gain Tinnitus Relief in 7 Days 2Health News:60 Second Panic Solution Review Exposes Simple Panic Attacks Remedy 2
... N.C., March 25 There is no guarantee ... after its initial launch. A,necessary first step for ... that ensures needed resources -- both financial and,staffing ... a study by benchmarking,leader Best Practices, LLC., ...
... Stanford University School of Medicine,s Todd Ferris, Associate ... of Information Privacy and Security; ... Engineer, WHAT: "Improving Network Security and Management", WHEN: ... EDUCAUSE Western Regional Conference 2008 ...
... March 25 Laerdal Medical,Corporation announces a ... MedAssets Supply Chain Systems has awarded Laerdal,a ... Products." The,contract is effective January 1 through ... ), Bruce Cadwell, Laerdal,s National ...
... Cancer with State-of-the-Art Technology, EAST RUTHERFORD, N.J., ... of the nation,s top 10 public relations firms, ... roster. Developed in New,Zealand, MoleSafe is a state-of-the-art ... moles and other suspicious lesions to,help detect early ...
... 25 Almost Family, Inc.,(Nasdaq: AFAM ) today ... home health agency owned by Apex Home Healthcare,Services, L.L.C. ... Company Comments on Combination, "We are very pleased ... of Apex to our Company, and we are excited ...
... pathogens - including ,superbug, MRSA-responsible ... March 25 The U.S. Environmental Protection,Agency (EPA) ... public health claims. These public health claims acknowledge ... harmful, potentially deadly,bacteria. Copper is the first solid ...
Cached Medicine News:Health News:Successful Drug Re-Launch Hinges on Organizational Backing 2Health News:Stanford University School of Medicine to Address 'Improving Network Security and Management' at EDUCAUSE Western Regional Conference 2008 Using Lancope's StealthWatch System for Network Behavior Analysis 2Health News:Laerdal Medical Announces Strategic Relationship 2Health News:MWW Group Retained by MoleSafe 2Health News:Almost Family Announces Acquisition of Apex Home Health 2Health News:Almost Family Announces Acquisition of Apex Home Health 3Health News:Almost Family Announces Acquisition of Apex Home Health 4Health News:U.S. EPA Approves Registration of Antimicrobial Copper Alloys 2
Shandon Laser MicroWriter is a laser labeling system developed specifically for anatomical pathology....
Modular Slide Storage Cabinet has a durable cold rolled steel construction with baked on epoxy finish. Drawers slide smoothly and quietly....
Store microscope slides with ease, speed, efficiency....
... offers special drawers for just about everything imaginable ... microscopy laboratory. Each box is designed for long ... the advantages of wood over metal systems is ... as a subtle kind of desiccator and insulator, ...
Medicine Products: